Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FIBRINOPEPTIDE A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 277 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Blann, AD; Gurney, D; Wadley, M; Bareford, D; Stonelake, P; Lip, GYH
      Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and vonWillebrand factor

      BLOOD COAGULATION & FIBRINOLYSIS
    2. Masuda, Y; Sugawara, J; Kawarada, Y; Sugiyama, T
      Lithium affects the reactivities of GalNAc alpha 1-3GalNAc-lipid and fibrinopeptide A in mice

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    3. Huang, YQ; Li, JJ; Hu, L; Lee, M; Karpatkin, S
      Thrombin induces increased expression and secretion of VEGF from human FS4fibroblasts, DU145 prostate cells and CHRF megakaryocytes

      THROMBOSIS AND HAEMOSTASIS
    4. Loreth, RM; Meyer, M; Albert, FW
      Fibrinogen kaiserslautern III: A new case of congenital dysfibrinogenemia with A alpha 16 Arg -> Cys substitution

      HAEMOSTASIS
    5. Trifiletti, A; Scamardi, R; Pizzoleo, MA; Sottilotta, G; Barbera, N; Frisina, N
      Increased indexes of thrombin activation in advanced stages of hypertension

      HAEMOSTASIS
    6. Masuda, Y; Sugiyama, T
      Human fibrinopeptide A mediates allergic reaction in mice in the acute phase

      PEPTIDES
    7. Miyamoto, S; Ogawa, H; Sakamoto, T; Soejima, H; Takazoe, K; Shimomura, H; Kajiwara, I; Yoshimura, M; Kugiyama, K; Nakamura, S; Ozaki, Y
      Platelet hyperaggregability persists even after the improvement of increased blood coagulation and impaired fibrinolysis with the stabilization of symptoms in patients with unstable angina

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    8. Miyamoto, S; Ogawa, H; Soejima, H; Takazoe, K; Kajiwara, I; Shimomura, H; Sakamoto, T; Yoshimura, M; Kugiyama, K; Yasue, H; Ozaki, Y
      Enhanced platelet aggregation in the coronary circulation after coronary spasm

      THROMBOSIS RESEARCH
    9. Hoffmeister, HM; Szabo, S; Helber, U; Seipel, L
      The thrombolytic paradox

      THROMBOSIS RESEARCH
    10. Shainoff, JR; Ratnoff, OD; Smejkal, GB; DiBello, PM; Welches, WR; Lill, H; Mitkevich, OV; Periman, P
      Confirmation of Mendelian properties of heterodimeric fibrinogen moleculesin a heterozygotic dysfibrinogenemia, "fibrinogen amarillo," using GPRphoresis to differentiate SemiFibrin molecules from fibrinogen and fibrin

      THROMBOSIS RESEARCH
    11. Ottani, F; Galvani, M
      Prognostic role of hemostatic markers in acute coronary syndromes patients

      CLINICA CHIMICA ACTA
    12. Tun, A; Khan, IA
      Myocardial infarction with normal coronary arteries: The pathologic and clinical perspectives

      ANGIOLOGY
    13. Ogawa, H; Soejima, H; Takazoe, K; Miyamoto, S; Kajiwara, I; Shimomura, H; Sakamoto, T; Yoshimura, M; Kugiyama, K; Kimura, M; Yasue, H
      Increased autoantibodies against oxidized low-density lipoprotein in coronary circulation in patients with coronary spastic angina

      ANGIOLOGY
    14. Minnema, MC; Peters, RJG; de Winter, R; Lubbers, YPT; Barzegar, S; Bauer, KA; Rosenberg, RD; Hack, CE; ten Cate, H
      Activation of clotting factors XI and IX in patients with acute myocardialinfarction

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    15. Morris, TA
      Low molecular weight heparins: Background and pharmacology

      SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    16. Armaganian, L; Kam, G; Eisenberg, PR; Schechtman, KB; Abendschein, DR
      Role of tissue factor-mediated coagulation in ischemia/reperfusion-inducedinjury of Langendorf-perfused rabbit hearts

      CORONARY ARTERY DISEASE
    17. Yamamoto, Y; Wakabayashi, G; Ando, N; Aikawa, N; Kitajima, M
      Increased fibrinolytic activity and body cavity coagula

      SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    18. Miwa, K; Nakagawa, K; Yoshida, N; Taguchi, Y; Inoue, H
      Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    19. Masuda, Y; Kawarada, Y; Sugiyama, T
      Behavioral effect of mouse fibrinopeptide A on mouse forced swimming

      PEPTIDES
    20. Wojtukiewicz, MZ; Rucinska, M; Zimnoch, L; Jaromin, J; Piotrowski, Z; Rozanska-Kudelska, M; Kisiel, W; Kudryk, BJ
      Expression of prothrombin fragment 1+2 in cancer tissue as an indicator oflocal activation of blood coagulation

      THROMBOSIS RESEARCH
    21. Miyamoto, S; Ogawa, H; Soejima, H; Takazoe, K; Kajiwara, I; Sakamoto, T; Yoshimura, M; Kugiyama, K; Yasue, H
      Increased rate of formation of small-sized platelet aggregates in patientswith acute coronary syndromes

      JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    22. Ogawa, H; Sakamoto, T; Nishiyama, K; Soejima, H; Kaikita, K; Takazoe, K; Miyamoto, S; Kugiyama, K; Yoshimura, M; Yasue, H
      Elevated levels of soluble intercellular adhesion molecule-1 in the coronary circulation of patients with coronary organic stenosis and spasm

      JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    23. Masuda, Y; Suzuki, M
      Repeated electroconvulsive shock treatment induces two humoral antidepressive factors in mouse.

      TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
    24. Kim, HK; Song, KS; Park, YS; Yun, YS; Shim, WH
      Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease

      CARDIOLOGY
    25. Dempfle, CE; Argiriou, S; Kucher, K; Muller-Peltzer, H; Rubsamen, K; Heene, DL
      Analysis of fibrin formation and proteolysis during intravenous administration of ancrod

      BLOOD
    26. Dempfle, CE; Argiriou, S; Kucher, K; Muller-Peltzer, H; Rubsamen, K; Heene, DL
      Analysis of fibrin formation and proteolysis during intravenous administration of ancrod

      BLOOD
    27. Zain, J; Huang, YQ; Feng, XS; Nierodzik, ML; Li, JJ; Karpatkin, S
      Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells

      BLOOD
    28. Hoffmeister, HM; Kastner, C; Szabo, S; Beyer, ME; Helber, U; Kazmaier, S; Baumbach, A; Wendel, HP; Heller, W
      Fibrin specificity and procoagulant effect related to the kallikrein-contact phase system and to plasmin generation with double-bolus reteplase and front-loaded alteplase thrombolysis in acute myocardial infarction

      AMERICAN JOURNAL OF CARDIOLOGY
    29. Umemoto, S; Suzuki, N; Fujii, K; Fujii, A; Fujii, T; Iwami, T; Ogawa, H; Matsuzaki, M
      Eosinophil counts and plasma fibrinogen in patients with vasospastic angina pectoris

      AMERICAN JOURNAL OF CARDIOLOGY
    30. Miyamoto, S; Ogawa, H; Soejima, H; Takazoe, K; Sakamoto, T; Yoshimura, M; Kugiyama, K; Yasue, H
      Formation of platelet aggregates after attacks at coronary spastic angina pectoris

      AMERICAN JOURNAL OF CARDIOLOGY
    31. Giansante, C; Fiotti, N; Miccio, M; Altamura, N; Salvi, R; Guarnieri, G
      Coagulation indicators in patients with paroxysmal atrial fibrillation: Effects of electric and pharmacologic cardioversion

      AMERICAN HEART JOURNAL
    32. Bauer, KA
      Activation markers of coagulation

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    33. Paramo, JA; Panizo, C; Montes, R; Orbe, J; Alegria, E; Martinez-Caro, D; Dooijewaard, G
      Markers of fibrinolytic potency and clotting activation in stable angina pectoris: role of urokinase, assessment of atrioventricular differences and correlation with coronary patency

      FIBRINOLYSIS & PROTEOLYSIS
    34. Moruzzi, P; Sarzi-Braga, S; Rossi, M; Contini, M
      Sleep apnoea in ischaemic heart disease: differences between acute and chronic coronary syndromes

      HEART
    35. Lind, SE; Goldshteyn, S; Barry, CP; Lindquist, JR; Piergies, AA; Rosen, T; Schneider, JR; Shevrin, DH; Caprini, JA
      Assessment of coagulation system activation using spot urine measurements

      BLOOD COAGULATION & FIBRINOLYSIS
    36. Sandbaek, G; Bjornsen, S; Brosstad, F
      Soluble, thrombin-related material in arterial thrombi and plasma studied during catheter-directed intra-arterial thrombolysis

      BLOOD COAGULATION & FIBRINOLYSIS
    37. Gurfinkel, E; Duronto, E; Colorio, C; Bozovich, G; Cohen, M; Mautner, B
      Thrombotic reactant markers in non-ST segment elevation acute coronary syndromes treated with either enoxaparin (low molecular weight heparin) or unfractionated heparin

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    38. Jensen, CM; Pilegaard, R; Hviid, K; Nielsen, JD; Nielsen, HJ
      Quality of reinfused drainage blood after total knee arthroplasty

      JOURNAL OF ARTHROPLASTY
    39. Li, YH; Teng, JK; Tsai, WC; Tsai, LM; Lin, LJ; Guo, HR; Chen, JH
      Prognostic significance of elevated hemostatic markers in patients with acute myocardial infarction

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    40. Oishi, M; Mochizuki, Y; Shikata, E
      Single lacunar brain infarction with transient signs versus those with long-lasting signs

      INTERNATIONAL ANGIOLOGY
    41. Dempfle, CE
      The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state

      THROMBOSIS AND HAEMOSTASIS
    42. McCarron, BI; Marder, VJ; Kanouse, JJ; Francis, CW
      A soluble fibrin standard: Comparable dose-response with immunologic and functional assays

      THROMBOSIS AND HAEMOSTASIS
    43. Linder, R; Oldgren, J; Egberg, N; Grip, L; Larson, G; Siegbahn, A; Wallentin, L
      The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease

      EUROPEAN HEART JOURNAL
    44. Giannitsis, E; Siemens, HJ; Mitusch, R; Tettenborn, I; Wiegand, U; Schmucker, G; Sheikhzadeh, A; Stierle, U
      Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    45. Kowalik-Jankowska, T; Jasionowski, M; Lankiewicz, L
      Copper(II) complexation by pituitary adenylate cyclase activating polypeptide fragments

      JOURNAL OF INORGANIC BIOCHEMISTRY
    46. Ince, B; Bayram, C; Harmanci, P; Ulutin, T
      Hemostatic markers in ischemic stroke of undetermined etiology

      THROMBOSIS RESEARCH
    47. Takazoe, K; Ogawa, H; Yasue, H; Sakamoto, T; Oshima, S; Arai, H; Moriyama, Y; Shimomura, H; Hirai, N; Kaikita, K; Soejima, H; Misumi, K; Hosoda, K
      Association of plasma levels of activated protein C with recanalization ofthe infarct-related coronary artery after thrombolytic therapy in acute myocardial infarction

      THROMBOSIS RESEARCH
    48. Lopez, Y; Paloma, MJ; Rifon, J; Cuesta, B; Paramo, JA
      Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states

      THROMBOSIS RESEARCH
    49. Rojnuckarin, P; Intragumtornchai, T; Sattapiboon, R; Muanpasitporn, C; Pakmanee, N; Khow, O; Swasdikul, D
      The effects of green pit viper (Trimeresurus albolabris and Trimeresurus macrops) venom on the fibrinolytic system in human

      TOXICON
    50. Fassbender, K; Dempfle, CE; Mielke, O; Schwartz, A; Daffertshofer, M; Eschenfelder, C; Dollman, M; Hennerici, M
      Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator

      STROKE
    51. Brummel, KE; Butenas, S; Mann, KG
      An integrated study of fibrinogen during blood coagulation

      JOURNAL OF BIOLOGICAL CHEMISTRY
    52. McKenzie, ME; Pothula, A; Gurbel, PA; Fuzaylov, SY; O'Connor, CM; Gattis, WA; Serebruany, VL
      Failure of thrombin generation markers to triage patients presenting with chest pain

      CARDIOLOGY
    53. Joist, JH
      AICF and DIC in liver cirrhosis: Expressions of a hypercoagulable state

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    54. Ben-Ari, Z; Osman, E; Hutton, RA; Burroughs, AK
      Disseminated intravascular coagulation in liver cirrhosis: Fact or fiction?

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    55. Ferrario, M; Repetto, A; Lucreziotti, S; Ardissino, D
      Low-dose fibrinolytics and glycoprotein Ilb/IIIa receptor blockade for thetreatment of acute myocardial infarction

      AMERICAN HEART JOURNAL
    56. Lehmann, KG; Gonzales, E; Tri, BD; Vaziri, ND
      Systemic and translesional activation of coagulation, fibrinolytic, and inhibitory systems in candidates for coronary angioplasty: Basal state and effect of successful dilation

      AMERICAN HEART JOURNAL
    57. GHIGLIOTTI G; WAISSBLUTH AR; SPEIDEL C; ABENDSCHEIN DR; EISENBERG PR
      PROLONGED ACTIVATION OF PROTHROMBIN ON THE VASCULAR WALL AFTER ARTERIAL INJURY

      Arteriosclerosis, thrombosis, and vascular biology
    58. PRISCO D; PANICCIA R; BANDINELLI B; GORI AM; ATTANASIO M; GIUSTI B; COMEGLIO M; ABBATE R; GENSINI GF; SERNERI GGN
      EFFECT OF LOW-DOSE HEPARIN ON FIBRINOGEN LEVELS IN PATIENTS WITH CHRONIC ISCHEMIC-HEART-DISEASE

      International journal of clinical & laboratory research
    59. BECKER RC; SPENCER FA
      THROMBIN - STRUCTURE, BIOCHEMISTRY, MEASUREMENT, AND STATUS IN CLINICAL MEDICINE

      Journal of thrombosis and thrombolysis
    60. OLTRONA L; MERLINI PA; SAVONITTO S; BROCCOLINO M; GIARRATANA G; PEZZANO A; MANNUCCI PM; ARDISSINO D
      LACK OF CORRELATION BETWEEN ACTIVATION OF HEMOSTATIC MECHANISM AND INFLAMMATION IN UNSTABLE ANGINA-PECTORIS

      Journal of thrombosis and thrombolysis
    61. TOSS H; ERNOFSSON M; WALLENTIN L; SEIGBAHN A
      NO PROGNOSTIC IMPORTANCE OF RESISTANCE TO ACTIVATED PROTEIN-C IN UNSTABLE CORONARY-ARTERY DISEASE DESPITE SIGNS OF THROMBIN ACTIVATION

      Journal of thrombosis and thrombolysis
    62. STEFANIDIS I; FRANK D; MAURIN N
      HEMOSTASIS ACTIVATION MARKERS IN ACUTE-RENAL-FAILURE

      Renal failure
    63. GRANGER CB; BECKER R; TRACY RP; CALIFF RM; TOPOL EJ; PIEPER KS; ROSS AM; ROTH S; LAMBREW C; BOVILL EG
      THROMBIN GENERATION, INHIBITION AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION TREATED WITH THROMBOLYTIC THERAPY AND HEPARIN - RESULTS FROM THE GUSTO-I TRIAL

      Journal of the American College of Cardiology
    64. WEERWIND PW; VANDERVEEN FH; LINDHOUT T; DEJONG DS; CAHALAN FT
      EX-VIVO TESTING OF HEPARIN-COATED EXTRACORPOREAL CIRCUITS - BOVINE EXPERIMENTS

      International journal of artificial organs
    65. BELLART J; GILABERT R; MIRALLES RM; MONASTERIO J; CABERO L
      ENDOTHELIAL-CELL MARKERS AND FIBRINOPEPTIDE-A TO D-DIMER RATIO AS A MEASURE OF COAGULATION AND FIBRINOLYSIS BALANCE IN NORMAL-PREGNANCY

      Gynecologic and obstetric investigation
    66. INOUE T; FUJITO T; HOSHI K; SAKAI Y; MOROOKA S; SOHMA R
      DETECTION AT PLATELETS ACTIVATED DURING ACETYLCHOLINE-INDUCED CORONARY VASOSPASM

      Thrombosis and haemostasis
    67. ERNOFSSON M; STREKERUD F; TOSS H; ABILDGAARD U; WALLENTIN L; SIEGBAHN A
      LOW-MOLECULAR-WEIGHT HEPARIN REDUCES THE GENERATION AND ACTIVITY OF THROMBIN IN UNSTABLE CORONARY-ARTERY DISEASE

      Thrombosis and haemostasis
    68. FALCIANI M; GORI AM; FEDI S; CHIARUGI L; SIMONETTI I; DABIZZI RP; PRISCO D; PEPE G; ABBATE R; GENSINI GF; SERNERI GGN
      ELEVATED TISSUE FACTOR AND TISSUE FACTOR PATHWAY INHIBITOR CIRCULATING LEVELS IN ISCHEMIC-HEART-DISEASE PATIENTS

      Thrombosis and haemostasis
    69. OHYAMA T; HORI Y; MORIIKE M; ASANO T; HAYASHI H; IWADE K; HOSODA S
      ANTITHROMBOTIC EFFECTS OF CX-397, A RECOMBINANT HIRUDIN ANALOG, IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS

      Thrombosis and haemostasis
    70. Murakami, Y; Shimada, T; Ishinaga, Y; Kinoshita, Y; Kin, H; Kitamura, J; Ishibashi, Y; Murakami, R
      Transcardiac 5-hydroxytryptamine release and impaired coronary endothelialfunction in patients with vasospastic angina

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    71. Martinez-Sales, V; Vila, V; Reganon, E; Goberna, MA; Ferrando, F; Palencia, MA; Aznar, J
      Elevated thrombotic activity after myocardial infarction: A 2-year follow-up study

      HAEMOSTASIS
    72. Reganon, E; Ferrando, F; Vila, V; Villa, P; Martinez-Sales, V; Fayos, L; Ruano, M; Aznar, J
      Increase in thrombin generation after coronary thrombolysis with rt-PA or streptokinase with simultaneous heparin versus heparin alone

      HAEMOSTASIS
    73. WEISS C; WELSCH B; ALBERT M; FRIEDMANN B; STROBEL G; JOST J; NAWROTH P; BARTSCH P
      COAGULATION AND THROMBOMODULIN IN RESPONSE TO EXERCISE OF DIFFERENT TYPE AND DURATION

      Medicine and science in sports and exercise
    74. WEISS C; SEITEL G; BARTSCH P
      COAGULATION AND FIBRINOLYSIS AFTER MODERATE AND VERY HEAVY EXERCISE IN HEALTHY MALE-SUBJECTS

      Medicine and science in sports and exercise
    75. WATKINS MW; LUETMER PA; SCHNEIDER DJ; WITMER WT; VAITKUS PT; SOBEL BE
      DETERMINANTS OF REBOUND THROMBIN ACTIVITY AFTER CESSATION OF HEPARIN IN PATIENTS UNDERGOING CORONARY INTERVENTIONS

      Catheterization and cardiovascular diagnosis
    76. SHIMADA K; KAWARABAYASHI T; KOMATSU R; SAKAMOTO T; SHIMIZU Y; YOSHIKAWA J
      EFFICACY AND SAFETY OF EARLY CORONARY STENTING FOR UNSTABLE ANGINA

      Catheterization and cardiovascular diagnosis
    77. Gando, S; Nanzaki, S; Sasaki, S; Aoi, K; Kemmotsu, O
      Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock

      CRITICAL CARE MEDICINE
    78. NISHIYAMA K; OGAWA H; YASUE H; SOEJIMA H; MISUMI K; KUGIYAMA K; TSUJI I; KUMEDA K
      HEPARIN-RELEASABLE ENDOTHELIAL CELL-ASSOCIATED TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IS INCREASED IN THE CORONARY CIRCULATION AFTER CORONARY SPASM IN PATIENTS WITH CORONARY SPASTIC ANGINA

      Thrombosis research
    79. MISUMI K; OGAWA H; YASUE H; SOEJIMA H; SUEFUJI H; NISHIYAMA K; TAKAZOE K; KUGIYAMA K; TSUJI I; KUMEDA K
      CIRCADIAN VARIATION IN PLASMA-LEVELS OF FREE-FORM TISSUE FACTOR PATHWAY INHIBITOR ANTIGEN IN PATIENTS WITH CORONARY SPASTIC ANGINA

      Japanese Circulation Journal
    80. Gurfinkel, E; Bozovich, G
      Chlamydia pneumoniae: inflammation and instability of the atherosclerotic plaque

      ATHEROSCLEROSIS
    81. WEITZ JI; LESLIE B; HUDOBA M
      THROMBIN BINDS TO SOLUBLE FIBRIN DEGRADATION PRODUCTS WHERE IT IS PROTECTED FROM INHIBITION BY HEPARIN-ANTITHROMBIN BUT SUSCEPTIBLE TO INACTIVATION BY ANTITHROMBIN-INDEPENDENT INHIBITORS

      Circulation
    82. XIAO ZH; THEROUX P
      PLATELET ACTIVATION WITH UNFRACTIONATED HEPARIN AT THERAPEUTIC CONCENTRATIONS AND COMPARISONS WITH A LOW-MOLECULAR-WEIGHT HEPARIN AND WITH A DIRECT THROMBIN INHIBITOR

      Circulation
    83. TOPOL EJ
      MYOCARDIAL REPERFUSION THERAPY - EMERGING PLATELET PREEMINENCE

      Circulation
    84. Hoffmeister, HM; Szabo, S; Kastner, C; Beyer, ME; Helber, U; Kazmaier, S; Wendel, HP; Heller, W; Seipel, L
      Thrombolytic therapy in acute myocardial infarction - Comparison of procoagulant effects of streptokinase and alteplase regimens with focus on the kallikrein system and plasmin

      CIRCULATION
    85. MANTEN A; DEWINTER RJ; MINNEMA MC; TENCATE H; LIJMER JG; ADAMS R; PETERS RJG; VANDEVENTER SJH
      PROCOAGULANT AND PROINFLAMMATORY ACTIVITY IN ACUTE CORONARY SYNDROMES

      Cardiovascular Research
    86. IVERSEN N; LINDAHL AK; ABILDGAARD U
      ELEVATED TFPI IN MALIGNANT DISEASE - RELATION TO CANCER TYPE AND HYPERCOAGULATION

      British Journal of Haematology
    87. NIERODZIK ML; CHEN K; TAKESHITA K; LI JJ; HUANG YQ; FENG XS; DANDREA MR; ANDRADEGORDON P; KARPATKIN S
      PROTEASE-ACTIVATED RECEPTOR 1 (PAR-1) IS REQUIRED AND RATE-LIMITING FOR THROMBIN-ENHANCED EXPERIMENTAL PULMONARY METASTASIS

      Blood
    88. GORKUN OV; HENSCHENEDMAN AH; PING LF; LORD ST
      ANALYSIS OF A-ALPHA-251 FIBRINOGEN - THE ALPHA-C DOMAIN HAS A ROLE INPOLYMERIZATION, ALBEIT MORE SUBTLE THAN ANTICIPATED FROM THE ANALOGOUS PROTEOLYTIC FRAGMENT-X

      Biochemistry (Easton)
    89. GURFINKEL E; FAREED J; ANTMAN E; COHEN M; MAUTNER B
      RATIONALE FOR THE MANAGEMENT OF CORONARY SYNDROMES WITH LOW-MOLECULAR-WEIGHT HEPARINS

      The American journal of cardiology
    90. SHIMOMURA H; OGAWA H; ARAI H; MORIYAMA Y; TAKAZOE K; HIRAI N; KAIKITA K; HIRASHIMA O; MISUMI K; SOEJIMA H; NISHIYAMA K; YASUE H
      SERIAL CHANGES IN PLASMA-LEVELS OF SOLUBLE P-SELECTIN IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

      The American journal of cardiology
    91. MISUMI K; OGAWA H; YASUE H; SOEJIMA H; SUEFUJI H; NISHIYAMA K; TAKAZOE K; KUGIYAMA K; TSUJI I; KUMEDA K; NAKAMURA S
      COMPARISON OF PLASMA TISSUE FACTOR LEVELS IN UNSTABLE AND STABLE ANGINA-PECTORIS

      The American journal of cardiology
    92. ARDISSINO D; MERLINI PA; EISENBERG P; KOTTKEMARCHANT K; CRENSHAW BS; GRANGER CB
      COAGULATION MARKERS AND OUTCOMES IN ACUTE CORONARY SYNDROMES

      The American heart journal
    93. KASUYA H; SHIMIZU T; TAKAKURA K
      THROMBIN ACTIVITY IN CSP AFTER SAH IS CORRELATED WITH THE DEGREE OF SAH, THE PERSISTENCE OF SUBARACHNOID CLOT AND THE DEVELOPMENT OF VASOSPASM

      Acta neurochirurgica
    94. PRISCO D; PANICCIA R; BANDINELLI B; GIUSTI B; COLELLA A; COMEGLIO M; ABBATE R; SIMONE I; GENSINI GF; SERNERI GGN
      SHORT-TERM ACE-INHIBITION MAY INFLUENCE EXERCISE-INDUCED CHANGES IN HEMOSTASIS IN HEALTHY-SUBJECTS

      Fibrinolysis & proteolysis
    95. HOFFMEISTER HM; JUR M; HELLER W; SEIPEL L
      LACK OF IMPACT OF ANGIOPLASTY ON THE TIME-COURSE OF ELEVATED COAGULATION AND FIBRINOLYSIS PARAMETERS IN UNSTABLE ANGINA-PECTORIS

      Fibrinolysis & proteolysis
    96. BAUER KA
      HOW TO DETECT ACTIVATED COAGULATION

      Fibrinolysis & proteolysis
    97. HOFFMEISTER HM; HELLER W; SEIPEL L
      MOLECULAR MARKERS OF HEMOSTASIS AND FIBRINOLYSIS AND INHIBITOR LEVELSIN UNSTABLE ANGINA-PECTORIS

      Fibrinolysis & proteolysis
    98. LEE LV; EWALD GA; MCKENZIE CR; EISENBERG PR
      THE RELATIONSHIP OF SOLUBLE FIBRIN AND CROSS-LINKED FIBRIN DEGRADATION PRODUCTS TO THE CLINICAL COURSE OF MYOCARDIAL-INFARCTION

      Arteriosclerosis, thrombosis, and vascular biology
    99. YASUE H; KUGIYAMA K
      CORONARY SPASM - CLINICAL-FEATURES AND PATHOGENESIS

      Internal medicine
    100. KAHN SR; SOLYMOSS S; FLEGEL KM
      NONVALVULAR ATRIAL-FIBRILLATION - EVIDENCE FOR A PROTHROMBOTIC STATE

      CMAJ. Canadian Medical Association journal


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/08/20 alle ore 05:23:38